Bupivacaine-induced contraction is attenuated by endothelial nitric oxide release modulated by activation of both stimulatory and inhibitory phosphorylation (Ser1177 and Thr495) of endothelial nitric oxide synthase
- Authors
- Lee, Soo Hee; Park, Chang-Shin; Ok, Seong-Ho; Kim, Dana; Kim, Kyung Nam; Hong, Jeong-Min; Kim, Ji-Yoon; Il Bae, Sung; An, Seungmin; Sohn, Ju-Tae
- Issue Date
- 15-Jun-2019
- Publisher
- Elsevier BV
- Keywords
- Bupivacaine; Endothelial nitric oxide; Endothelial nitric oxide synthase; Src kinase; Caveolin-1; Vasoconstriction
- Citation
- European Journal of Pharmacology, v.853, pp 121 - 128
- Pages
- 8
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- European Journal of Pharmacology
- Volume
- 853
- Start Page
- 121
- End Page
- 128
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/9047
- DOI
- 10.1016/j.ejphar.2019.03.026
- ISSN
- 0014-2999
1879-0712
- Abstract
- This study examined the mechanism associated with the endothelium-dependent attenuation of vasoconstriction induced by bupivacaine (BPV), with a particular focus on the upstream cellular signaling pathway of endothelial nitric oxide synthase (eNOS) phosphorylation induced by BPV in human umbilical vein endothelial cells (HUVECs). BPV concentration-response curves were investigated in the isolated rat aorta. The effects of N omega-nitro-L-arginine methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ), methylene blue, calmidazolium, the Src kinase inhibitor 4-amino-3-(4 chlorophenyl)-1-(t butyl)-1H-pyrazolo[3,4-d]pyrimidine, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) and the combination of L-arginine and L-NAME on BPV-induced contraction in endothelium-intact aorta preparations were examined. The effects of BPV alone and in combination with PP2 on the phosphorylation of eNOS (at Ser1177 or Thr495), caveolin-1 and Src kinase were examined in HUVECs. BPV-induced contraction was lower in endothelium-intact aortae than in endothelium-denuded aortae. L-NAME, ODQ, methylene blue and calmidazolium increased BPV-induced contraction in endothelium-intact aortae, whereas PP2 alone and combined treatment with c-arginine and L-NAME inhibited BPV-induced contraction. Low-concentration BPV (30 mu M) induced both stimulatory (Ser1177) and inhibitory (Thr495) phosphorylation of eNOS in HUVECs. However, high-concentration BPV (150 mu M) induced only stimulatory (Ser1177) eNOS phosphorylation. Additionally, phosphorylation of Src kinase, caveolin-1 and inhibitory eNOS (Thr495) induced by low-concentration BPV was inhibited by PP2. These results suggest that contraction induced by low-concentration BPV is attenuated by endothelial nitric oxide release, which is modulated both stimulatory (Ser1177) and inhibitory eNOS phosphorylation (Thr495). BPV-induced phosphorylation of eNOS (Thr495) is indirectly mediated by an upstream cellular signaling pathway involving Src kinase (Tyr416) and caveolin-1 (Tyr14).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.